Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

11.28
+0.37003.39%
Post-market: 11.350.0700+0.62%17:57 EDT
Volume:901.29K
Turnover:9.95M
Market Cap:218.17M
PE:-1.85
High:11.37
Open:10.81
Low:10.58
Close:10.91
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.47
T/O Rate:5.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:2.13
PE(LYR):-1.91

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
1 hour ago

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst

TIPRANKS
·
Aug 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 19

Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.0%, Outperforms Peers

Dow Jones
·
Aug 18

Corbus Grants CMO Inducement Awards Including Option for 191,676 Shares at $10.09 Exercise Price

Reuters
·
Aug 17

Corbus Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 17

Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 17

Corbus Pharmaceuticals price target lowered to $33 from $34 at Mizuho

TIPRANKS
·
Aug 17

Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating

MT Newswires Live
·
Aug 13

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 13

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Aug 13

Corbus Chief Business Officer Nishant Saxena Acquires 2,600 Shares Worth $25,037.44

Reuters
·
Aug 13

RBC Capital Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Aug 12

Corbus Pharma CFO Sean Moran Sells 12,000 Shares for $120,971

Reuters
·
Aug 11

Corbus Pharmaceuticals Holdings Inc. Stock Falls 7.0%, Underperforms Peers

Dow Jones
·
Aug 11

Corbus Pharmaceuticals - to Offer and Sell Common Stock up to $127.50 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Aug 08